solanezumab

0:02:45

Dr. Ronald Petersen discusses Alzheimer's research

0:00:57

An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial #dementia #alzheimers #clinicaltrials

0:23:25

Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial | Patient Perspectives

0:01:23

Solanezumab

0:21:59

Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial | Patient Perspectives

0:00:37

What does solanezumab mean?

0:02:51

New drug may attack Alzheimer's underlying cause, study finds

0:00:20

How to Pronounce Solanezumab

0:03:32

Eli Lilly Alzheimer's Drug Fails Major Test Trial

0:00:39

Alzheimer's and Amyloid #alzheimer

0:03:04

Clinical trial hailed as 'game changer' for Alzheimer's

0:03:00

Did Alzheimer's Drug Really Show a Clinical Benefit?

0:02:38

Drug makers take on Alzheimer’s

0:01:21

Dr. Max Gomez: Alzheimer’s Drugs

0:01:54

Challenges in developing anti-Aβ monoclonal antibodies for Alzheimer’s disease

0:01:58

BBC News - Alzheimer drug solanezumab may slow effects

0:01:00

What are the things that you should know when considering joining a clinical trial? #dementia

0:12:46

The Quest for Treatments for Alzheimer's Disease with Eric Siemers - On Our Mind

0:01:30

Eli Lilly's New Drug Could Lead To Alzheimer's Cure - Newsy

0:02:13

Solanezumab Failed to Halt Alzheimer's Progression

0:02:49

Testing anti-amyloid therapies in preclinical Alzheimer's disease

0:14:23

SOLANEZUMAB não funcionou, e agora? Remédio para ALZHEIMER?

0:00:37

Eli Lilly Drug Slows Alzheimer's in Major Trial

0:15:32

Engaging stakeholders for a holistic therapy in Alzheimer’s disease, Dr. Andrea Pfeifer